Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
That's all I need, enough to keep the ship steady and wait for the pre New year treat!
There appears to be a continuous trickling of contracts coming through which is great. However, need some form and monetary level of contracts to flow just to maintain current mcap. There are plenty more exciting opportunities with ORPH, but at this time it is 'steady eddie' which is not a bad thing. IMHO
Kt
No rns for that... not something significant
We may get a better one tho....just sayin
Moniman, agree with you re pointless ramping but disagree that OO has not demonstrated to the market that they are moving into profit. RNS Contract news since the loss making end Dec19 Results are as follows:
RNS Number : 7544Y 06 January 2020
3 Year Contract with major Pharmaceutical Company
Open Orphan, a European-focussed, rare and orphan drug consulting services platform, is pleased to announce the signing of a new 3-year contract with a tier 1 German pharmaceutical company which is one of Europe's top research-driven pharmaceutical companies. The contract guarantees significant annual revenue with work under the contract to commence this month.
Fri, 6th Mar 2020 07:00
RNS Number : 2129F
New hVIVO contract signed with a European Biotech Company Projected to deliver £3.2m in revenue in 2020 with the pivotal challenge study expected to commence end Q4 2020, with the potential to deliver significant further revenue expected to be a minimum of £7m.
Thu, 23rd Apr 2020 07:00
RNS Number : 5708K
Testing of anti-viral for treating COVID-19 underway
Open Orphan plc (ORPH) the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services, is pleased to announce that its London-based subsidiary hVIVO has commenced the testing of an anti-viral for treating COVID-19 on behalf of its client Nearmedic International Ltd.
Mon, 4th May 2020 07:00
RNS Number : 7378L
Major New Contract and Directorate Change
New contract signed with US Biotechnology Company for respiratory syncytial virus (RSV) human challenge study
Challenge study projected to deliver £3.5 million in revenue in 2020
Thu, 11th Jun 2020 07:00
Pleased to announce that it has signed a major contract with a leading vaccine developer and one of the top pharmaceutical companies in the world. The contract with Venn Life Sciences, which is part of Open Orphan, builds on earlier successful contracts between the companies and is to obtain and support market access of newly developed vaccines into the EU and US markets until the end of 2020.
Tue, 28th Jul 2020 07:00
RNS Number : 2256U
Open Orphan PLC
28 July 2020
Awarded Contract from Codagenix Inc. New York USA for COVID-19 Vaccine Trial
Pleased to announce a new contract with Codagenix Inc. ("Codagenix") to conduct a first in human (Phase I) trial evaluating safety and immunogenicity of a single-dose, intranasal SARS-CoV-2 (COVID-19) vaccine candidate in 48 healthy young adult volunteers
Tue, 4th Aug 2020 07:00
RNS Number : 0001V
New Contract Win with Carna Bioscience Carna Bioscience (www.carnabio.com) for a First In Human Clinical pharmacology trial. The contract is expected to deliver significant revenue for Venn Life Sciences ("Venn") over the next twelve months.
RNS Number : 5695V
10 August 2020
Major New Contract Win with Top 3 Pharma Company a new contract, valued at £4m,
I don't want to jinx anything but there is strength in this share price! Gla
Blah... I agree with your last sentence thats why :) As for audacity you're right i have high conviction but not because of charts per se' as that is a technical signal that should not trump fundamentals. I researched this company more than most that is why I am confident. The charts mirror the deals done on the Woodford fall out and the price points for both acacia's pretty rapid departure and the more sedate selling of the 24m holder ( i believe still to be Starboard). Charts in this scenario are very useful, as they provide real time info on margins for a known seller and their fixed price. Not the holy grail thou we can completely agree on that. All the best :)
Ok gents we can all calm down now, red days do bring out the worst in people. The good ship OO will have a blue day tomorrow when we wake up to the RNS that OO have partnered with Bionical for antibody testing, I’m sure the market will go crazy for the least significant part of this business. We can all be friends again then :)
Apologies deepjoy, I DID take that out of context, in fact I didn't even read it properly, so I should probably be subject to a barrage of criticism and shaming on this board. Nevertheless, I'm surprised at your confidence that you can prove reasons for SP movement by looking at charts: to my mind they only show historic prices, not reasons, let alone clues to future performance. Your blanket dismissal of fundamentals during this period is equally discombobulating. I'm staggered and gawping at your sheer audacity. At least you didn't take issue with my final, apparently indisputable contention.
Blah.. I am not sure who that is directed to but as you include reference to my post then please include the context that I put around it ..i.e the SP performance since the '5th June' (is actually down since that time) and to be frank any suggestion that near term profitability drove the SP from 5p I do not agree with at all .
Oh and BTW I have done very very well this year thank you, mainly because I have held this since December alongside some very selective other stocks. No all winners but the ones that matter are, including this one.
I don't understand talk of "poor SP performance" when it's trebled this calendar year. Makes me wonder how your other investments have done. Ultimately, it IS about profitability, and the massive rise partially reflects the perceived turnaround from previous loss-making positions across the businesses. The huge increase in traffic on the board shows that "sentiment" is high too, probably accounting for the rest of the SP gains so far, and the flaky volatility due to frenetic and indecisive short-term speculators.
It's not just coincidence that Moniman's moaning parallels the rising SP - he is clearly somehow fuelling it, and I urge him to continue.
We appear to be on the third downward cycle following 3 brilliant company news releases since 13th July. This is in many ways good news, a) if you had the conviction to trade (which i don't) or b) are patient as time and again the market has presented buy opportunities if one is prepared to concentrate on the number of shares they hold, not the intrinsic paper value fluctuations daily. The company hasn't changed, in fact on the contrary it is motoring on regardless and one day the true value will be reflected in the SP but only when the majority of market participants want to own the shares, not trade or skim the profits as and when they appear. What we have here is a very large institutional or otherwise trader taking marginal profits from retail buying their shares regardless. If you know this, and we do then the key is to work out their bottom margin to buy more at a very good price and HOLD, (or trade on the rise if that is your bag). I now own several hundred thousand of these and if the opportunity comes to buy more at circa 12.8 I will happily, even thou my account would show a loss of thousands paper profit from present levels. If the company story hasn't changed then don't change the story for the sake of the SP. top up 12.8 for me not before and I hope we don't (and do ) get there. GLA
The think is Moni you never back up your views with any evidence or logic other than talk about profitability. If profitability drove market sentiment than AIM would be non existent as most companies are loss making year on year. The only person who goes on Acacia is you also btw... With respect to state that the SP is no affected by the disposal of 38m shares and a further dilution of 20% from the last raise is beyond belief.
The charts from 5th June don't lie .... it is market fatigue behind the poor SP performance nothing more. People trading the movements in the knowledge that there is a persistent seller in our midst. If no one on here can get their head around the difference between the SP and the continual actual company progress then they have no place investing, especially on AIM.
We'll good for you. You appear to be like CJ's two yes men from the Rise and Fall of Reginald Perrin, I.e. Only agreeing with everything positve stated, whereas I'm quite happy to challenge the Status Quo and fictional myths about OO...lets just agree to disagree...
Moni I don’t ramp and I never once put a price on the share or any comments like boom, check if you want, GL.
Aimed at Barwickman and co..not last poster..
I'm not moaning I'm just pointing out the obvious facts as they stand. I'm invested but not peddling daily rumours about fictional price movement that don't materialise. You just don't get it, companies have to make profit or appear that they will, OO have yet to demonstrate that to the market. I'm fed up with rampers like you just making up prices...get real and stop moaning about my posts. If you've got some factual information then share it instead of repeating your whinging about my posts...
So obviously you don’t like the way things are panning out in ORPH, so why don’t you take the safe option and sell up that’s if your in , it’s just a constant moan from yourself , either put up or shut up .
when should we expect a trading update ?
Cut the crap...the fact is OO is not currently demonstrating to the market that it is making profit. Acacia selling is now old news..the market wants clear evidence of cash coming in and profit due the the previous history of cash burn from Venn and Hvivo. Say what you like about me, I'm just pointing out the facts, that most of you dreamers are failing to grasp..Lets wait for a trading update instead of rumours...
Moni think we could all say the same about you regarding the RNS,s , I thought you just had Tourette’s or maybe it’s just verbal diarrhoea lol.
Every share i follow is Red today, its everywhere, nothing specific with OO, everyone is getting some.
Yes here we are again post RNS red day. If I had a £pound for every post that said the SP was going to be x amount higher at the end of the week then I'd be a millionaire. This isn't about Acacia still selling, it's about the markets lack of sight on profitability.
Is it true that the Ruskys are now just considering the best delivery method: Front door knob (the Novichock method) in your tea (the pollonium 210 method), or the sharpened umbrella (arsenic poison method)....maybe that's part if the stage 3 study?
They have tested it on a whole 40 people!!
Putin is offering it free to the entire populations of Ukraine, Georgia, Turkey, the US and the Uk. The Uk version is called Novichok 2.